Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.

ADHD is a widely misunderstood condition. Knowing what ADHD is, and what it isn’t, can raise awareness of the condition and ...

A mental health influencer has shared six ways that having ADHD has made Christmas a living hell for his entire family.

Are rising ADHD diagnoses a cultural trend, a misunderstanding, or evidence of a real neurodevelopmental difference? This ...

Barcelona, Spain-based Grifols announced that its fibrinogen concentrate, Fesilty (fibrinogen, human-chmt), has been approved by the US Food and Drug Administration (FDA) for the treatment of acute ...

Far from rotting our brains, video games may improve our cognition. But how we play them matters when it comes to the benefits they provide. By playing video games, “people are practicing complex ...

Expanded access to mental health, medication, tech-based care and bereavement leave further cover popular and pressing needs.

Optum Behavioral Health, a Health Services Company with Over 48 Million Covered Lives, Joins Growing List of Insurers Now ...

Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, ...

The Montreal Cognitive Assessment is a 30-point exam meant to screen for Alzheimer's and other cognitive impairments in older adults.

As part of the PDAOAI initiative, Oncotelic has curated a comprehensive TGF-β literature corpus comprising more than 125,000 PubMed abstracts, representing the near-totality of scientific knowledge ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.